Renalytix (Reg S) (RENX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.78p
   
  • Change Today:
      0.53p
  • 52 Week High: 12.50
  • 52 Week Low: 5.62
  • Currency: UK Pounds
  • Shares Issued: 405.37m
  • Volume: 2,892,790
  • Market Cap: £35.58m
  • RiskGrade: 348
  • Beta: 0.07

Deal with Barclays    Trade now with Barclays Stockbrokers

Broker Views

Show broker recommendations:
Show broker actions:
Date Broker name New Price Old price target New price target Broker change

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Consensus broker estimates sourced from FactSet Research Systems Inc., who calculate consensus using only those estimates changed or actively validated within the last 75 days.

 

RENX Market Data

Currency UK Pounds
Share Price 8.78p
Change Today 0.53p
% Change 6.38 %
52 Week High 12.50
52 Week Low 5.62
Volume 2,892,790
Shares Issued 405.37m
Market Cap £35.58m
Beta 0.07
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

RENX Dividends

No dividends found

Trades for 07-Oct-2025

Time Volume / Share Price
15:01 34,706 @ 8.64p
14:56 555 @ 9.00p
14:30 821 @ 8.65p
14:16 2,752 @ 8.65p
14:16 81,136 @ 8.62p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page